IRBP (1-20), human
|
|
|
- CAS号:
- 298202-25-2
- 英文名:
- IRBP (1-20), human
- 英文别名:
- IRBP (1-20), human;L-Aspartic acid, glycyl-L-prolyl-L-threonyl-L-histidyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-prolyl-L-seryl-L-leucyl-L-valyl-L-leucyl-L-α-aspartyl-L-methionyl-L-alanyl-L-lysyl-L-valyl-L-leucyl-L-leucyl-
- 中文名:
- IRBP (1-20), human
- 中文别名:
- 光感受器间类视黄醇结合蛋白1-20
- CBNumber:
- CB74713738
- 分子式:
- C101H164N24O28S
- 分子量:
- 2194.62
- MOL File:
- 298202-25-2.mol
|
|
|
IRBP (1-20), human化学性质
-
沸点:
-
2184.9±65.0 °C(Predicted)
-
|
-
密度:
-
1.275±0.06 g/cm3(Predicted)
-
|
-
酸度系数(pKa):
-
2.89±0.10(Predicted)
-
|
IRBP (1-20), human性质、用途与生产工艺
IRBP (1-20), human 包含 H-2b 单倍型的主要表位。IRBP (1-20), human TFA 诱导 H-2b 小鼠实验性自身免疫性葡萄膜视网膜炎 (EAU)。
IRBP (1-20), human TFA induces EAU.
For determination of proliferative and cytokine responses, lymph node and spleen cells are collected 21 days after immunization and are stimulated in culture with the appropriate antigen. Cells of C57BL/6 mice and 129/J mice immunized with IRBP (1-20), human TFA proliferated in response to the peptide.
|
Animal Model:
|
C57BL/6 (H-2
b
b
[2]
|
|
Dosage:
|
200, 300 μg
|
|
Administration:
|
I.h.; After 21 days
|
|
Result:
|
C57BL/6 (H-2
b
b) also developed disease, albeit with a lower average score than C57BL/6.
|
IRBP (1-20), human
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-P1587 | 298202-25-2
IRBP (1-20), human | 298202-25-2 | 1mg | 1000元 |
| 2024/04/30 | HY-P1587 | 298202-25-2
IRBP (1-20), human | 298202-25-2 | 5mg | 3900元 |
298202-25-2, IRBP (1-20), human 相关搜索:
- 目录肽
- 目录多肽
- C101H164N24O28S
- 光感受器间类视黄醇结合蛋白1-20
- 298202-25-2
- IRBP (1-20), human
- L-Aspartic acid, glycyl-L-prolyl-L-threonyl-L-histidyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-prolyl-L-seryl-L-leucyl-L-valyl-L-leucyl-L-α-aspartyl-L-methionyl-L-alanyl-L-lysyl-L-valyl-L-leucyl-L-leucyl-